We are pleased to share the highlights from the BioHK2025 forum and exhibition. The event was successfully held on September 11, 2025, at the Hong Kong Convention and Exhibition Centre, where global experts gathered to explore "The Regulation and Development of Innovative Medical Devices”.

Dr. Desmond Hau, Director of Bio-Gene and Chairman of the forum, led discussions with three distinguished speakers from the Department of Health, the Chinese American Biomedical Association (CBA), and Hong Kong Accreditation Service (HKAS) Innovation and Technology Commission. They delved into critical topics such as "Medical Device Administrative Control System in Hong Kong", "US FDA Medical Device Regulation", and "HKAS Accreditation Services for Medical Testing", highlighting the promising future of innovation and development in medical devices.

We extend our sincere gratitude to all our speakers and participants for attending this forum and for continuously striving with us to advance innovation in biotechnology and medical devices.

BioHK, HKBIO, Medical Devices hk, Innovation hk, Biotech hk, IVD hk, Testing Industry hk, HK Department of Health, CBA, HKAS